HOLX vs SPRB · P/E 32, rev $4.10B vs rev $4.9M
Hologic Inc (HOLX) versus Spruce Biosciences Inc (SPRB) — a side-by-side from cached financials, not a winner call.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Latest reported SPRB revenue for 2024-12-31 was $4.9M. Net income was -$53.0M. Revenue was down 51.3% from 2023-12-31 to 2024-12-31. SPRB currently screens at market cap $3.0M.
HOLX currently screens at market cap $16.97B and trailing P/E 31.5. SPRB currently screens at market cap $3.0M.
Not investment advice. Open the HOLX and SPRB stock pages for the full models.
Not investment advice.